![]() |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cellcyte Genetics Corporation Summary: The class-action lawsuit against CellCyte for alleges violations of securities laws. According to the complaint CellCyte executives and business partners misled investors by publishing false information about the history and experience of the company’s chief executive officer. The lawsuit alleges that company shares were traded at artificially inflated prices due to the company’s activities. The company’s chief executive officer’s education and professional credentials were called into question after published news reports called out alleged discrepancies relating to his finance degree from the University of Washington, a CPA designation, ties to the Washington Society of Certified Public Accountants and a strong track record within the pharmaceutical industry. Soon after these reports company stock plummeted 55 percent. INDUSTRY CLASSIFICATION: SIC Code: 2834 Sector: Healthcare Industry: Biotechnology & Drugs
WARNING AND DISCLAIMER OF LIABILITY: The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful. Go to Search page | Go to Case Index page | Back to Top | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||